‌‌

Orthocell to start selling dental bone repair product Striate+ in Canada following regulatory approval

Headshot of Cheyanne Enciso
Cheyanne EncisoThe West Australian
Comments
Cheyanne Enciso

Shares in WA regenerative medicine company Orthocell are up after it received regulatory approval to start selling its dental bone repair product in Canada.

Manufactured at Orthocell’s Murdoch facility, Striate+ is a resorbable collagen membrane used for guided bone and tissue generation in dental procedures.

Subscribers with digital access can view this article.

Already a subscriber?

Enjoy exclusive member discounts, giveaways and competitions with our subscriber rewards program.